Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease

BACKGROUND: Anti-thyroid drug therapy is considered a treatment of choice for Graves' disease; however, treatment response varies among individuals. Although several studies have reported risk factors for relapse after initial treatment, few have assessed responsiveness during the early treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hoon Sung, Yoo, Won Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503874/
https://www.ncbi.nlm.nih.gov/pubmed/28685517
http://dx.doi.org/10.3803/EnM.2017.32.2.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503874/
https://www.ncbi.nlm.nih.gov/pubmed/28685517
http://dx.doi.org/10.3803/EnM.2017.32.2.281

Ejemplares similares